Making precision medicine a usable reality for all patients who could benefit from it
We’re a community-focused global convener, accelerator, and connector.
Who we are
The From Testing to Targeted Treatment Program (FT3), established in 2020, is a non-profit, multi-stakeholder global initiative. FT3 is bringing the right people together and building a neutral forum to reach the shared goal to make precision medicine a usable reality for all patients who could benefit from it.
FT3 is evolving with precision medicine, making it usable to all who can benefit. Anchored in expertise and humanity, we champion personalized healthcare, leveraging robust collaboration and co-creation across global and disciplinary boundaries.
Discover FT3’s publication calling for a new intersectoral collaborative approach for better patient outcomes:
Key facts
A global multi-stakeholder precision medicine accelerator
Bringing together and building on existing learnings and good practices
Shared decision making and solution building across wide-ranging stakeholder groups
Co-led by patients
Starting with testing and cancer
Bringing the right people together and building the forum to:
Grow a Community of Practice to share experiences and support local champions in improving access to personalized healthcare
Learn about local challenges, identify solutions and refine the community’s tools and learnings to accelerate access
Develop case studies to share learnings and good practices with the wider community
Creating practical tools for Precision Medicine champions and building momentum for collective action
Our Approach
Improving patient outcomes across three impact goals and nine strategic drivers.
Evidence-based Precision Medicine is accepted by decision-makers and is available and usable to patients:
Establish a common understanding of (the value of) Precision Medicine to create the right culture & readiness for change
Create a new biomarker testing resource by adapting this backbone resource to the relevant country and disease.
Access all adaptable resources for patients and patient organizations on Precision Medicine Synapse
Activation of Precision Medicine at healthcare delivery level:
Increase patient awareness and support patient empowerment
Accelerate efforts to address care level challenges to Precision Medicine along the entire patient pathway
Support HCPs and clinical shared decision-making to match patients with the most appropriate tests, treatments & trials
Unified and accelerated Precision Medicine ecosystem:
Build a global multi-stakeholder network and community of change agents
Identify scalable approaches to Precision Medicine to integrate PM into healthcare systems
Build world-class governance for credibility, agile growth, and impact
FT3 is a global accelerator of change, working together with wide-ranging stakeholders to identify common gaps, scale good practices and defragment efforts in precision medicine. Our goal is to share and support local good practices and build a backbone of expertise and practical resources that are designed to be adapted to support patient organizations and other precision medicine champions on the ground.